spacer
home > ebr > spring 2002 > vaccination - who should we trust?
PUBLICATIONS
European Biopharmaceutical Review

Vaccination - Who Should We Trust?

Increasing numbers of concerned parents in the UK are rebelling against MMR as theonly 'safe' vaccination alternative for their children. According to the results of a recent Guardian/ICM opinion poll (1), some 75 per cent of parents interviewed would like the UK Government to provide free separate measles, mumps and rubella vaccinations for their children. The overall results of the poll suggest that all the recent efforts made by the Government have had little or no impact in reducing popular anxiety over this matter. Only 20 per cent of those included in the survey said they would "trust a lot" the advice given by politicians and their officials, with a worrying 30 per cent disregarding it altogether. So is this a new crisis of trust in the governing bodies or are we facing the same problems over and over again? With the number of measles cases rising not only in the UK but in other European countries such as Germany - in some incidents to the point of epidemic clusters - we should all be reminded of the potential horrors of the infections being prevented by mass vaccination: a wider incidence of diseases striking the population, in some cases with potentially fatal results.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr Ian Gibson, Member of Parliament for Norwich North and Chair of the Commons Science and Technology Select Committee

Dr Ian Gibson was educated at Dumfries Academy and later attended Edinburgh University, where he was awarded a BSc and a PhD. He was a Royal Society Fellow at Edinburgh, and a Postdoctoral Fellow at Indiana University. Ian was also a visiting Professor at the University of Washington before joining the University of East Anglia (UEA) as a Lecturer in 1965. He was made a Senior Lecturer at UEA in 1970 and served as Dean of the School of Biological Sciences from 1991 to 1997. At UEA Ian was the head of a research team investigating various forms of cancer. In 1997 he was elected as Member of Parliament for Norwich North, a seat he kept after the 2001 election. In Parliament Ian specialised in science issues, particularly those relating to cancer research, founding the All Party Group on Cancer. During the last Parliament he was a member of the Commons Science and Technology select Committee, which he currently chairs, and was elected Chair of the Parliamentary Office of Science and Technology and the Parliamentary and Scientific Committee, a position he still holds.

spacer
Dr Ian Gibson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Igb Tamper Evident Folding Box

IGB

The easiest, safest and less expensive solution in compliance with what requires Dir. 62/2011/EU, FDA and TGA.
More info >>

 
Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement